InsiderTrades

Form 4 for CLNN Clene Inc.

Accepted 2024-07-30 00:00:00 ET · period of report 2024-07-29 · accession 0001562180-24-005867 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-07-30 2024-07-29 CLNN Etherington Robert Dee CEO, Dir M - OptEx $3.00 +27.3K 30.1K +966% +$82.0K
D 2024-07-30 2024-07-29 CLNN Etherington Robert Dee CEO, Dir M - OptEx $0.00 +27.3K 27.3K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-07-29 M A 27,320 $3.00 30,149 D — — (F1) On July 11, 2024, the common stock of Clene Inc. underwent a 1-for-20 reverse stock split, resulting in the reporting person's ownership in the previously disclosed 56,593 shares of common stock being reduced to 2,829 shares.
2 Derivative Stock Options (Right to buy) 2024-07-29 M A 27,320 $0.00 27,319 D $3.00 · 2014-07-31 to 2024-07-30 27,320 Common Stock (F6) On July 11, 2024, the common stock of Clene Inc. underwent a 1-for-20 reverse stock split, resulting in the reporting person's stock option grant of 1,092,777 options to purchase common stock being reduced to 54,639 options. The exercise option price for these options was increased from $0.15 per share to $3.00 per share.